San Francisco, California (CA) In Vitro and In Vivo Diagnostic Substances Companies

Featured companies
Cyto Wave Technologies Inc
201 Spear St # 1100
San Francisco CA 94105
(415) 583-9279
Folsom Diagnostics
349a Corbett Avenue
San Francisco CA 94114
(415) 244-1445
Run Them Sweet LLC
537a Simonds Loop
San Francisco CA 94129
(510) 292-5791
Not satisfied? Select a reasonRate this pageSend feedback

Or try our search form or quick navigation by category and location

Xcell Biosciences Inc
455 Mission Day Boulevard South
San Francisco CA 94158
(415) 937-0321
Annie Yang
219 Claremont Boulevard
San Francisco CA 94127
(415) 566-5286
Ipdx Biosciences Inc
182 Howard St 743
San Francisco CA 94105
Sierra Molecular Corp
239 Brannan St Unit 9d
San Francisco CA 94107
(604) 565-1495
Solidus Biosciences Inc
409 Illinois St.
San Francisco CA 94158
(415) 978-2160
Ucsf Viral Diagnostics
185 Berry St # 180a
San Francisco CA 94107
(415) 514-8219
Singular Bio Inc
1040 Dolores St Apartment 207
San Francisco CA 94110
(415) 826-9002
Intromed Inc
55 Francisco St # 380
San Francisco CA 94133
(415) 743-0081
Whereorg has 11 results under In Vitro and In Vivo Diagnostic Substances Companies in San Francisco, CA.

Narrow down the browsing criteria below to see more companies.

Select a category for location San Francisco, California

Other locations for category In Vitro and In Vivo Diagnostic Substances


Top Stories
UBS flags buyback possibility after Second-quarter earnings beat
UBS , the world's largest wealth manager, on Tuesday signalled the possibility of resuming share buybacks later this year after generating more income than expected in the first six months and as it boosted...
Tue, Jul 21 2020
Greece calls EU recovery fund deal a 'national success'
Prime Minister Kyriakos Mitsotakis called a European Union deal on a post-pandemic recovery fund a "national success" that would allocate Greece around 72 billion euros ($82.38 billion) to help deal with...
Tue, Jul 21 2020
UBS second-quarter net profit dips as Swiss business dampens trading bonanza
UBS , the world's largest wealth manager, saw net profit drop 11% in the second quarter as higher trading activity failed to offset a pandemic-induced slump in retail and corporate banking.
Tue, Jul 21 2020